SCHEMBL1745461

SCHEMBL1745461

O=C(c1ccccc1)N(Oc1ccc2[nH]ccc2c1)S(=O)(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.45
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CACNA1B Q00975 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
IDH1 O75874 1/20 0.40
KAT6A Q92794 1/20 0.39
MAPT P10636 2/20 0.39
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
AR P10275 1/20 0.38
ESR2 Q92731 1/20 0.38
CCR2 P41597 1/20 0.38
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1744608 0.88 SLC6A2 (0.46) ESR1SLC6A2SLC6A4SLC6A3MAPT
SCHEMBL1742890 0.84 MAPT (0.43) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL1742891 0.73 MAOA (0.40) SLC6A2SLC6A4SLC6A3MAPTLMNA
SCHEMBL1745458 0.70 BRAF (0.46) ESR1MEN1KMT2AIDH1NR3C1
SCHEMBL28207032 0.69 ESR1 (0.54) ESR1IDH1
SCHEMBL8869584 0.68 TTBK1 (0.49) ESR1SLC6A2SLC6A4SLC6A3TRPV1
SCHEMBL15979945 0.68 CTNNB1 (0.69) ESR1TRPV1IDH1CTNNB1WNT3A
SCHEMBL1744461 0.68 HSD11B1 (0.42) MEN1KMT2AMAPT
SCHEMBL6168385 0.67 ESR1 (0.82) ESR1MEN1KMT2ATRPV1MAPT
SCHEMBL1354825 0.65 TDP1 (0.50) CTNNB1WNT3ALMNAGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387560-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2011-11-23 EP claimed
US-8042193-B1 Systems and methods for controlling data access by use of a universal anonymous identifier Albright Associates (US) 2011-10-18 US claimed
WO-2010083441-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-07-22 WO claimed